Bali Muralidhar
CIK 1784138 · last filed 2025-07-24
Bali Muralidhar is a corporate insider who has filed 23 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for SPRB, was dated Jul 24, 2025. Across all open-market trades the lifetime net is +$10.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $106.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$106.12M
3
23
$10.19M
Holdings By Company
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-24 | SPRB | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | SPRB | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | SPRB | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | XCUR | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | SPRB | Grant (A) | — | $0 | EDGAR |
| 2022-05-19 | XCUR | Buy (P) | +1,472,126 | $285.2K | EDGAR |
| 2021-07-15 | OnKure Therapeutics, Inc. (RPHM) Delisted | Buy (P) | +111,736 | $949.8K | EDGAR |
| 2021-06-25 | OnKure Therapeutics, Inc. (RPHM) Delisted | Buy (P) | +20,710 | $192.2K | EDGAR |